Managing painful inflammatory processes is challenging enough, but many patients present with concurrent conditions that require complex treatments.

Dr Stephen Paget discusses the growing role of biomarkers in diagnosing and managing rheumatologic conditions.

Dr Stephen Paget discusses the growing role of biosimilar medications in rheumatology.

Jonathan Kay describes a patient with an extensive rash that initially suggested dermatomyositis but turned out to auger something more serious.

The MBDA score may be able to distinguish between patients who need biologic therapy and those who will do fine on nonbiologic therapy.

Art Caplan speaks with ethicist and author Dr. Barron Lerner about his new book, his physician father, and how medical ethics have changed over the years.

Dr. Jonathan Kay reviews biosimilar studies presented at EULAR 2014.

Dr. Jonathan Kay discusses the recent approval of apremilast for psoriatic arthritis. What will its therapeutic role be?

Dr. Stephen Paget discusses a patient with giant cell arteritis but a normal erythrocyte sedimentation rate and negative temporal artery biopsy.

Negative HCV RNA in a man with mixed cryoglobulinemia -- crack the case.